FDA recall D-0323-2020

Sato Pharmaceutical Inc. · Class III · drug

Product

Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535

Reason for recall

Subpotent Drug

Distribution

Nationwide within the United States, Guam and Saipan

Key facts

Status
Terminated
Initiation date
2019-10-01
Report date
2019-11-20
Termination date
2020-08-18
Voluntary/Mandated
Voluntary: Firm initiated
Location
Torrance, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0323-2020